Clinuvel Pharmaceuticals Stock
Clinuvel Pharmaceuticals Stock
The price for the Clinuvel Pharmaceuticals stock decreased slightly today. Compared to yesterday there is a change of -€0.015 (-0.160%).
Our community identified positive and negative aspects for Clinuvel Pharmaceuticals stock for the coming years. 1 users see the criterium "Valuation (undervalued/overvalued)" as a plus for the Clinuvel Pharmaceuticals stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.
Pros and Cons of Clinuvel Pharmaceuticals in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clinuvel Pharmaceuticals vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Clinuvel Pharmaceuticals | -0.160% | 1.028% | 5.659% | -15.213% | -4.687% | -50.200% | -49.731% |
Carbylan Therapeutics Inc | 0.910% | -3.540% | -2.679% | 22.472% | 0.926% | -50.455% | -48.994% |
Pharma Mar S.A. | -0.380% | 5.217% | 28.490% | 2.571% | -13.868% | -57.313% | - |
Starpharma Holdings Ltd. | 6.420% | -12.121% | -17.143% | -78.519% | -38.624% | -94.423% | -92.516% |